Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00391209
What this trial is testing

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 379
Post-approval studies (Phase 4)UnknownNCT02327663
What this trial is testing

Emtricitabine for Naive Chinese Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Asian-Pacific Alliance of Liver Disease, Beijing 2,000
Testing effectiveness (Phase 2)Study completedNCT00393120
What this trial is testing

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

Who this might be right for
HIV Infections
Incyte Corporation 45
Post-approval studies (Phase 4)Study completedNCT00871780
What this trial is testing

A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Biogen 224
Early research (Phase 1)Study completedNCT01274624
What this trial is testing

Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer

Who this might be right for
KRAS Mutant Metastatic Colorectal Cancer
Oncolytics Biotech 36
Large-scale testing (Phase 3)Study completedNCT02044380
What this trial is testing

Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 14
Large-scale testing (Phase 3)Study completedNCT06799546
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy

Who this might be right for
PNH
Haisco Pharmaceutical Group Co., Ltd. 73
Not applicableEnrolling By InvitationNCT07230795
What this trial is testing

AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 7,120
Large-scale testing (Phase 3)Study completedNCT02438722
What this trial is testing

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
SWOG Cancer Research Network 174
Post-approval studies (Phase 4)UnknownNCT02301806
What this trial is testing

Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM

Who this might be right for
Type 2 Diabetes
Dokkyo Medical University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05669664
What this trial is testing

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

Who this might be right for
Locally Advanced Salivary Gland CarcinomaMetastatic Salivary Gland CarcinomaRecurrent Salivary Gland Carcinoma+1 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT04385407
What this trial is testing

Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients

Who this might be right for
Chronic Hepatitis C Virus Infection
Beni-Suef University 203
Not applicableStudy completedNCT00391352
What this trial is testing

FMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to Controls

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Waukesha Memorial Hospital 21
Large-scale testing (Phase 3)UnknownNCT05204628
What this trial is testing

Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib

Who this might be right for
Non-small Cell Lung Cancer
Xuanzhu Biopharmaceutical Co., Ltd. 238
Testing effectiveness (Phase 2)Study completedNCT01628692
What this trial is testing

Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 230
Not applicableStudy completedNCT00879411
What this trial is testing

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Who this might be right for
Hypertension
Boehringer Ingelheim 670
Not applicableLooking for participantsNCT06872463
What this trial is testing

Karolinska Schizophrenia Project

Who this might be right for
Schizophrenia and Disorders with Psychotic Features
Karolinska Institutet 200
Large-scale testing (Phase 3)UnknownNCT02173951
What this trial is testing

An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients

Who this might be right for
Beta Thalassemia Major
Ain Shams University 64
Large-scale testing (Phase 3)Study completedNCT01591122
What this trial is testing

Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 313
Testing effectiveness (Phase 2)Looking for participantsNCT03980002
What this trial is testing

A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 50
Next Page